معرفی
Roles and Affiliations: Dmitry Abramov is an Associate Professor of Medicine at Loma Linda University's School of Medicine. He specializes in cardiovascular diseases, with a focus on heart failure, myocardial infarction, and pulmonary embolism. He actively leads and participates in numerous clinical trials and research projects, including the PROTECT IV Trial (Impella®-Supported PCI) and the PROACTIVE-HF Trial (Pulmonary Artery Sensor System).
Research Interests: Abramov's work centers on improving outcomes for patients with heart failure, optimizing cardiovascular care through novel therapies, and understanding the epidemiology of cardiovascular diseases. His research integrates clinical trials, population health studies, and translational medicine to address critical gaps in cardiovascular care. Key areas include the impact of obesity on cardiovascular outcomes, the role of SGLT-2 inhibitors in adult congenital heart disease, and the use of extracorporeal life support in high-risk pregnancies.
Grants and Projects:
- Principal Investigator for the PROACTIVE-HF Trial (Endotronix, Inc., 2025–2026).
- Principal Investigator for a database study on cardiomyopathy clinic patients (LLU Dept. of Medicine, 2022–2023).
- Principal Investigator for a pilot study on HCV-positive heart grafts (LLU Dept. of Medicine, 2021–2022).
Labs/Teams: Abramov collaborates with multidisciplinary teams across cardiology, emergency medicine, and obstetrics to advance translational research and clinical care.
